Skip to content

Bare Lymphocyte Syndrome: An Overview and Its Treatment

Share

Bare Lymphocyte Syndrome is an illness that results from seriously retreated conditions of a gene. It also results from the insufficiencies in the major histocompatibiltiy complex, which is broken down into Type I and Type II. Major histocompatibiltiy complex is a massive gene family that can be found in most vertebrates.

The Type II, which is associated to the class 2 of major histocompatibiltiy complex, is an unusual recessive genetic condition and these results in an incompetent and compromised immune system. This is also known as a serious combined immunodeficiency.  Furthermore, Bare Lymphocyte Syndrome can cause patients to be exceedingly at risk to infectious illness.

The genetic basis for this condition is not due to errors in the MHC II genes themselves. The genetic basis is the outcome of transformations in genes that code for proteins that usually control the gene transcription of the MHC II genes. That is, one of the many proteins that are needed to control on MHC II genes in a variety of cells kinds is absent.

Patients can suffer from chronic diarrhea, infections in the ear and even various kinds of pneumonia. Still, while it may look like that Bare Lymphocyte Syndrome is due to MHC II gene deficiencies, it is not really the genetic basis for this condition. The source of this sort of disease result is from protein coded genes that are altered and are not capable to appropriately control the expression of the MHC II genes. Presently, the only medication for this condition is through a bone marrow transplant.

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Faves
  • MySpace
  • StumbleUpon
  • Technorati
  • TwitThis

Post a Comment

You must be logged in to post a comment.